S&N silicon dressing can prevent pressure ulcers: Study

A hospital hallway
A foam dressing
An Allevyn Life dressing--Courtesy of Smith & Nephew

New research from Smith & Nephew ($SNN) showed that hospital-acquired pressure ulcers (HAPUs) could be significantly decreased via an ulcer prevention program which included the use of a silicone foam dressing.

The study--which was conducted in an adult intensive care unit at Eskenazi Health in Indianapolis between 2012-13--showed the prevention program resulted in a 69% decrease of HAPUs. This in turn could have potentially resulted in almost $1 million saved for Eskenazi, the announcement said.

Allevyn Life is a silicone foam dressing which can also be used to treat or prevent pressure ulcers. Thanks to the positive results, Eskenazi has approved a hospital-wide rollout of the HAPU prevention program.

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

“This study validates the need for a comprehensive, proactive, collaborative prevention program in hospitals,” said Rachel Culpepper, a registered nurse at Eskenazi Health, in the announcement. “Although it is difficult to isolate the effects of individual program components, silicone foam dressings can complement an existing pressure ulcer prevention program, and are believed to contribute to the reduction in HAPUs.”

As part of the HAPU prevention program, staff at Eskenazi were educated on the tech and were to adhere to specific protocols for patient care. The announcement noted that both are a proven part for the program to be effective in reducing HAPUs in the ICU.

- here's the press release

Related Articles: 
GE tech hub develops innovative handheld probe for bedsore monitoring
Hospital requires use of wireless, wearable sensors to prevent bedsores

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.